1. Th17 response in patients with cervical cancer (Review)
    Jayra Alves et al, 2018, Oncology Letters CrossRef
  2. The role of Th17 cells in viral infections
    Parisa Shiri Aghbash et al, 2021, International Immunopharmacology CrossRef
  3. The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?
    Markus Joerger et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
  4. Rationalizing heptadecaphobia: TH17 cells and associated cytokines in cancer and metastasis
    Jöran Lücke et al, 2021, The FEBS Journal CrossRef
  5. Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination
    Zhijia Sun et al, 2023, Journal for ImmunoTherapy of Cancer CrossRef
  6. High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer
    Estela Maria Silva et al, 2017, PLOS ONE CrossRef
  7. IL-17A and IL-17F orchestrate macrophages to promote lung cancer
    Nathalia Ferreira et al, 2020, Cellular Oncology CrossRef
  8. The Molecular Role of IL-35 in Non-Small Cell Lung Cancer
    Yuqiu Hao et al, 2022, Frontiers in Oncology CrossRef
  9. Comprehensive genomic and prognostic analysis of the IL‑17 family genes in lung cancer
    Tingting Liao et al, 2019, Molecular Medicine Reports CrossRef
  10. Role of IL-23 signaling in the progression of premalignant oral lesions to cancer
    Blaine Caughron et al, 2018, PLOS ONE CrossRef

  11. Clinical Role of Serum Interleukin-17A in the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children


    Jiuling Zhao et al, 2020, Infection and Drug Resistance CrossRef
  12. Identification of key genes in chronic intermittent hypoxia-induced lung cancer progression based on transcriptome sequencing
    Li-Da Chen et al, 2024, BMC Cancer CrossRef
  13. IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer
    Ran You et al, 2018, Cancer Immunology Research CrossRef
  14. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
    Erin A. Marshall et al, 2016, Molecular Cancer CrossRef
  15. Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma
    Claire L. Meaney et al, 2017, Oncotarget CrossRef
  16. IL‑17 induces NSCLC A549 cell proliferation via the upregulation of HMGA1, resulting in an increased cyclin D1 expression
    Chenhui Zhao et al, 2018, International Journal of Oncology CrossRef
  17. The role of IL-17 in lung cancer growth
    Liping Liu et al, 2023, Cytokine CrossRef
  18. The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
    Kevin Leone et al, 2018, Diagnostics CrossRef
  19. The paradox of Th17 cell functions in tumor immunity
    Zahra Asadzadeh et al, 2017, Cellular Immunology CrossRef
  20. Physiological roles of human interleukin‐17 family
    Yucong Liu et al, 2024, Experimental Dermatology CrossRef
  21. Thrombospondin-1 as a Potential Therapeutic Target: Multiple Roles in Cancers
    Pengfei Wang et al, 2020, Current Pharmaceutical Design CrossRef
  22. Combining multi-mode thermal therapy with IL-6 and IL-17A neutralization amplifies antitumor immunity to facilitate long-term survival in LLC1-bearing mice
    Jiamin Zheng et al, 2024, Med-X CrossRef